Olin Corporation Earnings Call Transcripts
Fiscal Year 2025
-
Fourth quarter 2025 results were below expectations due to operational and market headwinds, but strong cash generation and disciplined cost actions supported liquidity. 2026 will remain challenging, with cost savings and selective growth initiatives expected to drive gradual improvement, especially in Epoxy and Winchester.
-
Q3 2025 saw strong core alkaline and vinyls results, offset by weak epoxy and Winchester commercial sales. Section 45V tax credits boosted EBITDA, while aggressive inventory actions and cost initiatives are underway. Military demand remains robust, and Q4 EBITDA is guided lower due to inventory reduction.
-
Second quarter results showed stable chlorine values and strong cash flow despite ongoing trough demand and operational headwinds. Winchester's defense segment outperformed, while commercial ammunition and epoxy faced margin pressure. Tariff and market uncertainties continue to weigh on the outlook.
-
Q1 saw improved chlor-alkali and vinyls results, resilient caustic pricing, and strong military ammunition demand, offset by weak commercial sales and ongoing epoxy challenges. Cost reduction targets and capital discipline were increased, with positive outlooks for caustic and Winchester's military segment.
Fiscal Year 2024
-
Fourth quarter results benefited from lower hurricane costs and a share price-related gain, with strong CAPV and military ammunition demand offsetting weak commercial sales. 2025 guidance calls for flat ECU values and continued cost discipline, with improvement expected in Winchester in the second half.
-
Management outlined a disciplined strategy focused on cost reduction, core optimization, and high-return growth in chemicals and ammunition. New 2029 targets include $2B adjusted EBITDA, $250M+ cost savings, and >50% cash return to shareholders, with upside from growth options and sustainability initiatives.
-
Q3 results were heavily impacted by Hurricane Beryl, with a $110M EBITDA hit, but core chemical businesses showed sequential improvement and strong caustic pricing. Outlook for Q4 remains cautious due to lingering hurricane effects and weak demand, while capital discipline and shareholder returns continue.
-
Q2 saw modest improvement in chemicals and strong military sales in Winchester, but Hurricane Beryl will impact Q3 by ~$100 million. Full-year EBITDA guidance is lowered, with disciplined capital allocation and share repurchases continuing.